- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06173843
Occupational Exposures Among Firefighters
November 12, 2024 updated by: Vincere Cancer Center
Effect of Occupational Exposures on Cancer Pathophysiology Among Firefighters
This study aims to understand the effect of occupational exposures, including PFAS exposures, among firefighters.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christine Lau, MD
- Phone Number: 480-306-5390
- Email: drlau@vincerecancer.com
Study Locations
-
-
Arizona
-
Scottsdale, Arizona, United States, 85260
- Recruiting
- Vincere Cancer Center
-
Contact:
- Christine Lau, MD
- Phone Number: 480-306-5390
- Email: drlau@vincerecancer.com
-
Contact:
- Vershalee Shukla, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Actively working or retired firefighters of any adult age, any gender and any demographic group are eligible, with no limitations regarding general health status other than those specified in the protocol Eligibility Criteria.
Description
Inclusion Criteria:
- 18 years of age or older; any gender
- Currently (or previously) employed as a firefighter, full-time or part-time, participating in Vincere's First Responder Cancer Screening Program
- Willing to provide a blood, urine, and/or tissue sample
- Able to provide informed consent to participate in the study
(A small group of non-firefighters will be enrolled to act as a comparison group)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Firefighters
|
PFAS / heavy metal concentrations, exposure survey
|
|
Non-Firefighters
|
PFAS / heavy metal concentrations, exposure survey
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Exposures associated with elevated PFAS
Time Frame: 5 years
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cancer rates
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 6, 2023
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2029
Study Registration Dates
First Submitted
December 7, 2023
First Submitted That Met QC Criteria
December 7, 2023
First Posted (Actual)
December 18, 2023
Study Record Updates
Last Update Posted (Estimated)
November 14, 2024
Last Update Submitted That Met QC Criteria
November 12, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- VCC-PFAS-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
Clinical Trials on PFAS / heavy metal testing, exposures
-
Mayo ClinicActive, not recruitingArthroplasty, Replacement, Knee | Total Knee Replacement | Blood Metal Ion ConcentrationUnited States
-
Assiut UniversityNot yet recruitingColorectal Neoplasms
-
Fred Hutchinson Cancer CenterNational Institute of Mental Health (NIMH); Asociación Civil Via Libre, Peru; Epicentro, PeruActive, not recruitingHIV/AIDS | HIV Prevention | Feasibility Studies | HIV Testing | Implementation Science | Social Determinants of Health | Mobile Health | Health Services Accessibility | Linkage to Care | Qualitative Research | Global HealthPeru
-
The University of Texas Medical Branch, GalvestonNot yet recruitingAthletic InjuriesUnited States
-
Inotek Pharmaceuticals CorporationCompletedOcular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)United States
-
St. Jude Children's Research HospitalCompletedLymphoma | Neuroblastoma | High-risk TumorUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingHearing Loss | Metastatic Malignant Germ Cell Tumor | Metastatic Malignant Nongerminomatous Germ Cell Tumor | Metastatic Malignant Testicular Non-Seminomatous Germ Cell Tumor | Metastatic Testicular Seminoma | Stage II Testicular Cancer AJCC v8 | Stage III Testicular Cancer AJCC v8United States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingMalignant Germ Cell Tumor | Germ Cell Tumor | Childhood Extracranial Germ Cell Tumor | Extragonadal Embryonal Carcinoma | Malignant Ovarian Teratoma | Stage I Ovarian Choriocarcinoma | Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7 | Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7 | Stage I Testicular... and other conditionsUnited States, Canada, Japan, Australia, Puerto Rico, New Zealand, United Kingdom, Saudi Arabia, India
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood MedulloblastomaUnited States, Canada